Jin Zhou

Jin Zhou currently serves as the Director of Clinical Pharmacology at Gilead Sciences, focusing on the inflammation therapeutic area since January 2022. Prior to this role, Jin Zhou worked at Boehringer Ingelheim for nearly a decade, holding positions such as Senior Associate Director of Translational Medicine & Clinical Pharmacology, where responsibilities included leading early clinical development and asset programs in inflammation, overseeing sNDA submissions, and serving as a consultant on clinical pharmacokinetics within the inflammation therapeutic area. Previous roles at Boehringer Ingelheim also included Principal Scientist in Drug Metabolism and Pharmacokinetics and Senior Scientist, with a focus on PBPK modeling initiatives. Jin Zhou began their career as a Postdoctoral Fellow at Alliance Pharma, Inc. and completed an internship in the Department of Drug Metabolism & Pharmacokinetics at Boehringer Ingelheim Pharmaceuticals. Academic credentials include a PhD in Drug Metabolism from the University of Minnesota, a BS in Pharmacy from Fudan University, and an online certificate from Harvard Medical School in the HMX Fundamentals program.